Latest Feature

Gov. Deval Patrick's life sciences legacy

MassDevice.com looks at the life sciences legacy of former Massachusetts Gov. Deval Patrick.

Weight loss: ReShape Medical's Duo balloon system looks to curb obesity

A Q&A with ReShape Medical CEO Richard Thompson on the company's cash pay procedure and how it can make a dent in obese patients.

DeviceTalks podcast: Masimo CEO Kiani

An interview with medtech entrepreneur Joe Kiani, CEO of Masimo Corp. and the founder of the Patient Safety Movement Foundation, recorded at DeviceTalks West Nov. 19, 2014.

HeartFlow wins FDA OK for non-invasive FFR system

The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.

DeviceTalks podcast: B. Braun Medical CEO Caroll Neubauer on device tax, Obamaca

Caroll Neubauer, the CEO of B. Braun Medical, sits down for a wide-ranging interview on the hottest topics facing the medical device industry.

Latest Jobs

Knowledge Library

This document is a collection of articles relating to the mechanical testing of adhesives, textiles, and needles used in medical applications. This document is
Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

PAD: Philips teams up with Dutch center on new diabetic foot imaging

May 26, 2015 by Mark Hollmer

Philips says it will work with Amsterdam's Academic Medical Center to test a new imaging technique designed to help treat diabetics who have restricted blood flow in their feet.

Philips teams up with Dutch center on new diabetic foot imaging

ClarVista raises $14m Series B round

May 26, 2015 by Mark Hollmer

ClarVista Medical says it pulled in $14 million in a Series B round for its new intraocular lens replacement used after cataract surgery.

ClarVista raises $14m Series B round

California startup ClarVista Medical said it raised a $14 million Series B round slated for development of its adjustable post-cataract surgery intraocular lens replacement. Cycad Group and Windham Venture Partners co-led the round, along with existing investor New Enterprise Associates, ClarVista said.

HRS 2015: Boston Scientific, St. Jude Medical come out looking good

May 26, 2015 by Fink Densford

Analyst: Boston Scientific and St. Jude Medical stand out at the annual meeting of the Heart Rhythm Society in Boston.

HRS 2015: Boston Scientific, St. Jude Medical come out looking good

The outlook for ablation and cardiac rhythm management technologies is looking up, according to Leerink Partners analyst Danielle Antalffy, writing after reviewing the latest offerings from medical device companies at the annual Heart Rhythm Society meeting in Boston recently.

PureTech seeks $160m in U.K. listing

May 26, 2015 by MassDevice

Life science venture investing and incubation firm PureTech Health looks to raise $160 million in an initial public offering on the London Stock Exchange.

PureTech seeks $160m in U.K. listing

(Reuters) — Boston-based PureTech Health plans to raise $160 million in a London listing, filling its coffers to fund product development and delivering a vote of confidence on the British life sciences sector.

The move by the U.S. health technology firm follows a similar decision by California-based drug discovery group Verseon to raise $100 million in London earlier this month.

MassDevice.com +3 | The top 3 medtech stories for May 22, 2015

May 22, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Lumicell receives FDA nod for feasibility trial

May 22, 2015 by Fink Densford

Lumicell says it received approval from the FDA for a pilot feasibility study of its intraoperative breast cancer imaging system.

Lumicell receives nod from FDA for feasibility trial

Lumicell Diagnostics said it won an investigational device exemption from the FDA for a pilot feasibility trial of its imaging system for breast cancer surgeries.

The study is slated to be conducted at the Mass. General Hospital in Boston, the company said.

Warburg Pincus takes majority stake in Sterigenics

May 22, 2015 by Fink Densford

Private equity firm Warburg Pincus takes out a majority stake in contract sterilization company Sterigenics.

Warburg Pincus takes majority stake in Sterigenics

Private equity firm Warburg Pincus acquired a majority stake in contact sterilization provider Sterigenics International, according to GTCR, which bought the company in 2011.